Neovasc to Present at LEERINK Partners 7th Annual Global Healthcare Conference
12 February 2018 - 11:00PM
PR Newswire (US)
NASDAQ, TSX: NVCN
VANCOUVER, Feb. 12, 2018 /PRNewswire/ - Neovasc Inc.
("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced
that Fred Colen, President and Chief
Executive Officer of Neovasc, is scheduled to present at the
LEERINK Partners 7th Annual Global Healthcare Conference
on Wednesday, February
14th at 2:30 pm
ET at the Lotte New York Palace in New York City.
A live audio webcast of the presentation will be available on
the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina, which is not
currently available in the United
States and has been available in Europe since 2015, and the Tiara™, for the
transcatheter treatment of mitral valve disease, which is currently
under clinical investigation in the
United States, Canada and
Europe. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2018 PR Newswire
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jul 2023 to Jul 2024